FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy
A phase 2 trial of Fluoroestradiol F-18 in Breast cancer, run by National Cancer Institute (NCI), active and no longer recruiting.
Overview
FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy is a phase 2 interventional study registered as NCT02398773 by National Cancer Institute (NCI), with 99 participants planned, started 2016-05-04 and due to reach its primary completion in 2026-12-31. Interventions recorded: Computed Tomography, F-18 16 Alpha-Fluoroestradiol, Laboratory Biomarker Analysis, Positron Emission Tomography. Conditions recorded: HER2/Neu Negative, Progesterone Receptor Negative, Progesterone Receptor Positive, Stage IV Breast Cancer AJCC v6 and v7.
Linked to the drug Fluoroestradiol F-18 because the registry names it among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialStereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer
Shares Fluoroestradiol F-18 (FES PET), Breast cancer (all types) and the tag pipeline.
- Trial18F-fluoroestradiol (FES) PET/CT for Breast Cancer
Shares Fluoroestradiol F-18 (FES PET), Breast cancer (all types) and the tag pipeline.
- TrialSerial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy
Shares Fluoroestradiol F-18 (FES PET), Breast cancer (all types) and the tag pipeline.
- TrialImplementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
Shares Breast cancer (all types) and the tag pipeline.
- TrialCryoablation Versus Lumpectomy in Early-Stage Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.
- TrialPrevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling
Shares Breast cancer (all types) and the tag pipeline.
- TrialComparative Study of Scalp Cooling System and Chemical Cold Cap (COHAIR Study)
Shares Breast cancer (all types) and the tag pipeline.
- TrialDiagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.